Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaidya Sane Ayurved Laboratories Ltd

₹ 146 0.31%
11 Dec 3:49 p.m.
madhavbaug.org NSE - SME: MADHAVBAUG
About

Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]

Key Points

Business Overview:[1][2][3]
VSALL is a chain of Cardiac Care Clinics and hospitals that have 350+ Clinics, out of these 54 are company-owned, 62 are OPD’s Mini Clinic and 234 are franchised clinics. These are run by 450+ Ayurvedic Physicians. Company also has 2 hospitals viz. Madhavbaug Hospital, Khopoli (NABH Accredited) and Madhavbaug Hospital Nagpur.

Website NSE - SM
  • Market Cap ₹ 154 Cr.
  • Current Price ₹ 146
  • High / Low ₹ 251 / 107
  • Stock P/E 38.0
  • Book Value ₹ 56.0
  • Dividend Yield 0.00 %
  • ROCE 7.44 %
  • ROE 3.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 2.62 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
45.59 53.58 51.10 48.23 41.80
41.43 49.90 48.41 46.41 36.03
Operating Profit 4.16 3.68 2.69 1.82 5.77
OPM % 9.12% 6.87% 5.26% 3.77% 13.80%
0.83 0.54 0.63 1.12 0.83
Interest 0.11 0.07 0.16 0.09 0.08
Depreciation 1.16 1.44 1.59 1.56 1.93
Profit before tax 3.72 2.71 1.57 1.29 4.59
Tax % 26.61% 22.51% 24.84% 37.21% 28.98%
2.73 2.09 1.18 0.80 3.25
EPS in Rs 2.60 1.99 1.12 0.76 3.09
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 TTM
99.17 99.32 90.03
90.64 93.94 82.44
Operating Profit 8.53 5.38 7.59
OPM % 8.60% 5.42% 8.43%
1.36 1.75 1.95
Interest 0.86 1.12 0.17
Depreciation 2.60 3.14 3.49
Profit before tax 6.43 2.87 5.88
Tax % 24.88% 30.31%
4.83 1.98 4.05
EPS in Rs 4.59 1.88 3.85
Dividend Payout % 5.44% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 24%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -35%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Sep 2024
Equity Capital 10.51 10.51 10.51
Reserves 29.94 45.09 48.35
0.13 1.68 1.13
14.30 13.61 12.15
Total Liabilities 54.88 70.89 72.14
20.95 28.02 30.59
CWIP 1.67 2.60 2.39
Investments 15.33 3.22 3.98
16.93 37.05 35.18
Total Assets 54.88 70.89 72.14

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
0.06 -4.41
0.52 1.49
-1.38 14.46
Net Cash Flow -0.80 11.55

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 22.05 26.31
Inventory Days
Days Payable
Cash Conversion Cycle 22.05 26.31
Working Capital Days -1.91 6.84
ROCE % 7.44%

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Sep 2024
66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34%
33.67% 33.66% 33.68% 33.67% 33.67% 33.66% 33.66% 33.66% 33.66%
No. of Shareholders 493464534595637731846881821

Documents

Announcements

Annual reports

Concalls